| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI)
BCLI Technical Analysis
2.5
| As on 21st Jul 2025 BCLI STOCK Price closed @ 0.74 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.78 & Strong Buy for SHORT-TERM with Stoploss of 0.44 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BCLISTOCK Price
| Open | 0.00 | Change | Price | % |
| High | 0.00 | 1 Day | -0.43 | -36.75 |
| Low | 0.00 | 1 Week | -0.50 | -40.32 |
| Close | 0.74 | 1 Month | -0.38 | -33.93 |
| Volume | 383507 | 1 Year | 0.42 | 131.25 |
| 52 Week High 3.25 | 52 Week Low 0.22 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| OPEN | 3.22 | -11.05% |
| NVDA | 175.40 | -0.14% |
| INTC | 23.54 | -6.99% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| SOFI | 22.52 | -1.01% |
| TSLA | 323.90 | -1.64% |
| LCID | 2.09 | -1.88% |
| LILM | 0.05 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| BCLI Daily Charts |
BCLI Intraday Charts |
Whats New @ Bazaartrend |
BCLI Free Analysis |
|
|
BCLI Important Levels Intraday
| RESISTANCE | 0.74 |
| RESISTANCE | 0.74 |
| RESISTANCE | 0.74 |
| RESISTANCE | 0.74 |
| RESISTANCE | 0.74 |
| RESISTANCE | 0.74 |
| RESISTANCE | 0.74 |
| RESISTANCE | 0.74 |
BCLI Forecast August 2025
| 4th UP Forecast | 1.74 |
| 3rd UP Forecast | 1.42 |
| 2nd UP Forecast | 1.22 |
| 1st UP Forecast | 1.02 |
| 1st DOWN Forecast | 0.46 |
| 2nd DOWN Forecast | 0.26 |
| 3rd DOWN Forecast | 0.06 |
| 4th DOWN Forecast | -0.26 |
BCLI Weekly Forecast
| 4th UP Forecast | 0.91 |
| 3rd UP Forecast | 0.86 |
| 2nd UP Forecast | 0.82 |
| 1st UP Forecast | 0.79 |
| 1st DOWN Forecast | 0.69 |
| 2nd DOWN Forecast | 0.66 |
| 3rd DOWN Forecast | 0.62 |
| 4th DOWN Forecast | 0.57 |
BCLI Forecast2025
| 4th UP Forecast | 7.89 |
| 3rd UP Forecast | 5.6 |
| 2nd UP Forecast | 4.18 |
| 1st UP Forecast | 2.76 |
| 1st DOWN Forecast | -1.28 |
| 2nd DOWN Forecast | -2.7 |
| 3rd DOWN Forecast | -4.12 |
| 4th DOWN Forecast | -6.41 |
Brainstorm Cell Therapeutics Inc ( NASDAQ USA Symbol : BCLI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BCLI Business Profile
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company holds rights to develop and commercialize its NurOwn technology that utilizes cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and in Phase II for the treatment of progressive multiple sclerosis and alzheimer's disease, as well as for other central nervous system disorders. The company has a partnership with Catalent for the manufacture of NurOwn. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York. Address: 1325 Avenue of Americas, New York, NY, United States, 10019
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service